Stem cells versus senescence: The yin and yang of cardiac health

Journal of the American College of Cardiology

Volumn 65, Issue 2, 2015, Pages 148-150

  Behfar, Atta ^a   Terzic, Andre ^a  

^a MAYO CLINIC   (United States)

Author keywords

Aging; Biomarkers; Clinical trials; Heart failure; Ischemic heart disease; Regenerative medicine; Therapy

Indexed keywords

MOLECULAR MARKER; NUCLEOSTEMIN; PROTEIN KINASE PIM 1; UNCLASSIFIED DRUG; CARRIER PROTEIN; NUCLEAR PROTEIN; NUCLEOSTEMIN PROTEIN, MOUSE;

CARDIAC STEM CELL; CELL AGING; HEART FAILURE; HEART INFARCTION; HUMAN; MESENCHYMAL STEM CELL TRANSPLANTATION; ONCOGENE C MYC; REVIEW; SENESCENCE; STEM CELL; TISSUE REGENERATION; AGING; ANIMAL; BIOSYNTHESIS; CYTOLOGY; FEMALE; HEART MUSCLE; HEART VENTRICLE REMODELING; MALE; MESENCHYMAL STROMA CELL; MYOCARDIAL ISCHEMIA; PHYSIOLOGY; PROCEDURES; REJUVENATION;

AGING; ANIMALS; CARRIER PROTEINS; CELL AGING; FEMALE; HUMANS; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MYOCARDIAL ISCHEMIA; MYOCARDIUM; NUCLEAR PROTEINS; REJUVENATION; STEM CELLS; VENTRICULAR REMODELING;

EID: 84922616724     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2014.10.041     Document Type: Editorial

References (20)

1. Go AS, Mozaffarian D, Roger VL, et al. Heart disease and stroke statistics-2014 update: A report from the American Heart Association. Circulation 2014;129:e28-292.
2. Jahangir A, Sagar S, Terzic A. Aging and cardioprotection. J Appl Physiol 2007;103: 2120-8.
3. Terzic A, Waldman S. Chronic diseases: The emerging pandemic. Clin Transl Sci 2011;4:225-6.
4. Fisher SA, Brunskill SJ, Doree C, Mathur A, Taggart DP, Martin-Rendon E. Stem cell therapy for chronic ischaemic heart disease and congestive heart failure. Cochrane Database Syst Rev 2014;4: CD007888.
5. Dimmeler S, Ding S, Rando TA, Trounson A. Translational strategies and challenges in regenerative medicine. Nat Med 2014;20:814-21.
6. Baker DJ, Dawlaty MM, Wijshake T, et al. Increased expression of BubR1 protects against aneuploidy and cancer and extends healthy lifespan. Nat Cell Biol 2013;15:96-102.
7. Baker DJ, Wijshake T, Tchkonia T, et al. Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature 2011; 479:232-6.
8. van Deursen JM. The role of senescent cells in ageing. Nature 2014;509:439-46.
9. Naylor RM, Baker DJ, van Deursen JM. Senescent cells: A novel therapeutic target for aging and age-related diseases. Clin Pharmacol Ther 2013; 93:105-16.
10. Tchkonia T, Zhu Y, van Deursen J, Campisi J, Kirkland JL. Cellular senescence and the senescent secretory phenotype: Therapeutic opportunities. J Clin Invest 2013;123:966-72.
11. Golpanian S, El-Khorazaty J, Mendizabal A, et al. Effect of aging on human mesenchymal stem cell therapy in ischemic cardiomyopathy patients. J Am Coll Cardiol 2015;65:125-32.
12. Hariharan N, Quijada P, Mohsin S, et al. Nucleostemin rejuvenates cardiac progenitor cells and antagonizes myocardial aging. J Am Coll Cardiol 2015;65:133-47.
13. Cogle CR, Wise E, Meacham AM, et al., for the Cardiovascular Cell Therapy Research Network (CCTRN). A detailed analysis of bone marrow from patients with ischemic heart disease and left ventricular dysfunction: BM CD34, CD11b and clonogenic capacity as biomarkers for clinical outcomes. Circ Res 2014;115:867-74.
14. Behfar A, Terzic A. Stem cell in the rough: Repair quotient mined out of a bone marrow niche. Circ Res 2014;115:814-6.
15. Telukuntla KS, Suncion VY, Schulman IH, Hare JM. The advancing field of cell-based therapy: Insights and lessons from clinical trials. J Am Heart Assoc 2013;2:e000338.
16. Conboy IM, Conboy MJ, Wagers AJ, Girma ER, Weissman IL, Rando TA. Rejuvenation of aged progenitor cells by exposure to a young systemic environment. Nature 2005;433:760-4.
17. Behfar A, Yamada S, Crespo-Diaz R, et al. Guided cardiopoiesis enhances therapeutic benefit of bone marrow human mesenchymal stem cells in chronic myocardial infarction. J Am Coll Cardiol 2010;56:721-34.
18. Bartunek J, Behfar A, Dolatabadi D, et al. Cardiopoietic stem cell therapy in heart failure: The C-CURE (Cardiopoietic stem Cell therapy in heart failURE) multicenter randomized trial with lineage-specified biologics. J Am Coll Cardiol 2013;61:2329-38.
19. Terzic A, Behfar A. Regenerative heart failure therapy headed for optimization. Eur Heart J 2014; 35:1231-4.
20. Behfar A, Crespo-Diaz R, Terzic A, Gersh BJ. Cell therapy for cardiac repair-lessons from clinical trials. Nat Rev Cardiol 2014;11:232-46.